Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model

Cancer Biology and Therapy

Volumn 12, Issue 4, 2011, Pages 278-287

  Rainusso, Nino ^a,b   Man, Tsz Kwong ^a,b   Lau, Ching C ^a,b   Hicks, John ^b,c   Shen, Jianhe J ^a,b   Yu, Alexander ^a   Wang, Lisa L ^a,b   Rosen, Jeffrey M ^b  

^a TEXAS CHILDREN S CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Bone; Gene expression; Orthotopic; Osteosarcoma; PKH26; Sarcosphere; Tumor initiating cells

Indexed keywords

CXCL14 CHEMOKINE; MATRIX METALLOPROTEINASE 14; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN CDC42; PROTEIN KINASE WNK1; SOMATOMEDIN C; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR NANOG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; CELL MIGRATION; CELL RENEWAL; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR INITIATING CELL; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; FLUORESCENT DYES; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANIC CHEMICALS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS;

EID: 84860390025     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.4.15951     Document Type: Article

References (53)

1. Heppner G.H., Miller B.E. Tumor heterogeneity: Biological implications and therapeutic consequences. Cancer Metastasis Rev 1983; 2:5-23; DOI: 10.1007/BF00046903.
2. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3:895-902; DOI: 10.1038/nrc1232.
3. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: Models and concepts. Annu Rev Med 2007; 58:267-284; DOI: 10.1146/annurev.med.58.062105.204854.
4. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-3988; DOI: 10.1073/pnas.0530291100.
5. Charafe-Jauffret E., Ginestier C., Iovino F., Wicinski J., Cervera N., Finetti P., et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009; 69:1302-1313; DOI: 10.1158/0008-5472.CAN-08-2741.
6. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004; 101:781-786; DOI: 10.1073/pnas.0307618100.
7. Dontu G., Wicha M.S. Survival of mammary stem cells in suspension culture: Implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia 2005; 10:75-86; DOI: 10.1007/s10911-005-2542-5.
8. Dirks P.B. Brain tumor stem cells: Bringing order to the chaos of brain cancer. J Clin Oncol 2008; 26:2916-2924; DOI: 10.1200/JCO.2008.17.6792.
9. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-768; DOI: 10.1038/nrc2499.
10. Jones C., Mackay A., Grigoriadis A., Cossu A., Reis-Filho J.S., Fulford L., et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. Cancer Res 2004; 64:3037-3045; DOI: 10.1158/0008-5472.CAN-03- 2028.
11. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439:993-997 (Pubitemid 43292419)
12. Kusumbe A.P., Bapat S.A. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 2009; 69:9245-9253; DOI: 10.1158/0008-5472.CAN-09-2802.
13. Pece S., Tosoni D., Confalonieri S., Mazzarol G., Vecchi M., Ronzoni S., et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010; 140:62-73; DOI: 10.1016/j.cell.2009. 12.007.
14. Horan P.K., Melnicoff M.J., Jensen B.D., Slezak SE Fluorescent cell labeling for in vivo and in vitro cell tracking Methods Cell Biol 1990; 33:469-90; PubMed DOI: 10.1016/S0091-679X(08)60547-6.
15. Boutonnat J., Barbier M., Muirhead K., Mousseau M., Grunwald D., Ronot X., et al. Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: Simultaneous assessment of proliferation, apoptosis and necrosis. Cytometry 2000; 42:50-60; DOI: 10.1002/(SICI)1097-0320(20000215)42: 1⟨50::AIDCYTO8⟩3.0.CO;2-C.
16. Marina N., Gebhardt M., Teot L., Gorlick R Biology and therapeutic advances for pediatric osteosarcoma Oncologist 2004; 9:422-41; DOI: 10.1634/theoncologist. 9-4-422.
17. Gibbs C.P., Kukekov V.G., Reith J.D., Tchigrinova O., Suslov O.N., Scott E.W., et al. Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 2005; 7:967-976; DOI: 10.1593/neo.05394.
18. + cancer stem cells in human solid tumours. PLoS ONE 2008; 3:3469; DOI: 10.1371/journal.pone.0003469.
19. Levings P.P., McGarry S.V., Currie T.P., Nickerson D.M., McClellan S., Ghivizzani S.C., et al. Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res 2009; 69:5648-5655; DOI: 10.1158/0008-5472.CAN-08-3580.
20. Adhikari A.S., Agarwal N., Wood B.M., Porretta C., Ruiz B., Pochampally R.R., et al. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res 2010; 70:4602-4612; DOI: 10.1158/0008-5472.CAN-09-3463.
21. Luu H.H., Kang Q., Park J.K., Si W., Luo Q., Jiang W., et al. An orthotopic model of human osteosarcoma Growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 2005; 22:319-329; DOI: 10.1007/s10585-005-0365- 9.
22. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1:313-323; DOI: 10.1016/j.stem.2007.06.002.
23. Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T. Opinion: Migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5:744-749; DOI: 10.1038/nrc1694.
24. Man T.K., Chintagumpala M., Visvanathan J., Shen J., Perlaky L., Hicks J., et al. Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res 2005; 65:8142-8150; DOI: 10.1158/0008-5472.CAN-05-0985.
25. Cleton-Jansen A.M., Anninga J.K., Briaire-de Bruijn I.H., Romeo S., Oosting J., Egeler R.M., et al. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 2009; 101:1909-1918; DOI: 10.1038/sj.bjc.6605405.
26. Kubista B., Klinglmueller F., Bilban M., Pfeiffer M., Lass R., Giurea A., et al. Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma. Int Orthop 2011; 35:401-411; DOI: 10.1007/s00264-010-0996-6.
27. Di Cosimo S., Baselga J Management of breast cancer with targeted agents: importance of heterogeneity [corrected] Nat Rev Clin Oncol 7:139-47; DOI: 10.1038/nrclinonc.2009.234.
28. Dennis G. Jr, Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: Database for annotation, visualization and integrated Discovery. Genome Biol 2003; 4:3; DOI: 10.1186/gb-2003-4-5-p3.
29. Wang L., Park P., Lin C.Y. Characterization of stem cell attributes in human osteosarcoma cell lines. Cancer Biol Ther 2009; 8:543-552; DOI: 10.4161/cbt.8.6.7695.
30. Klein M.J., Siegal G.P. Osteosarcoma: Anatomic and histologic variants. Am J Clin Pathol 2006; 125:555-581; DOI: 10.1309/UC6KQHLD9LV2KENN.
31. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-5828 (Pubitemid 37187480)
32. Clarke M.F., Fuller M. Stem cells and cancer: Two faces of eve. Cell 2006; 124:1111-1115; DOI: 10.1016/j.cell.2006.03.011.
33. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9:391-403; DOI: 10.1016/j.ccr.2006.03.030.
34. Rikhof B., De Jong S., Suurmeijer A.J., Meijer C., Van der Graaf W.T. The insulin-like growth factor system and sarcomas. J Pathol 2009; 217:469-482; DOI: 10.1002/path.2499.
35. Zhang M., Xuan S., Bouxsein M.L., Von Stechow D., Akeno N., Faugere M.C., et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002; 277:44005-44012; DOI: 10.1074/jbc.M208265200.
36. Kappel C.C., Velez-Yanguas M.C., Hirschfeld S., Helman L.J. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 1994; 54:2803-2807 (Pubitemid 24173778)
37. Pollak M., Sem A.W., Richard M., Tetenes E., Bell R. Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy. J Natl Cancer Inst 1992; 84:966-971; DOI: 10.1093/jnci/84.12.966.
38. Kolb E.A., Kamara D., Zhang W., Lin J., Hingorani P., Baker L., et al. R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts. Pediatr Blood Cancer 2010; 55:67-75.
39. Ehlen H.W., Buelens L.A., Vortkamp A. Hedgehog signaling in skeletal development. Birth Defects Res C Embryo Today 2006; 78:267-279; DOI: 10.1002/bdrc.20076.
40. Jiang J., Hui C.C. Hedgehog signaling in development and cancer. Dev Cell 2008; 15:801-812; DOI: 10.1016/j.devcel.2008.11.010.
41. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010; 141:52-67; DOI: 10.1016/j.cell.2010. 03.015.
42. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007; 128:683-692; DOI: 10.1016/j.cell.2007.01.029.
43. Zhang M., Behbod F., Atkinson R.L., Landis M.D., Kittrell F., Edwards D., et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 2008; 68:4674-4682; DOI: 10.1158/0008-5472.CAN-07- 6353.
44. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2:329-333; DOI: 10.1038/nprot.2007.30.
45. Saito Y., Kitamura H., Hijikata A., Tomizawa-Murasawa M., Tanaka S., Takagi S., et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med 2:17.
46. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431:1112-1117; DOI: 10.1038/nature03043.
47. Lanzkron S.M., Collector M.I., Sharkis S.J. Hematopoietic stem cell tracking in vivo: A comparison of short-term and long-term repopulating cells. Blood 1999; 93:1916-1921 (Pubitemid 29128493)
48. R Development Core Team. R: A language and environment for statistical computing. Available at: http://www.R-project.org/. Vienna, Austria: R Foundation for Statistical Computing 2011.
49. Smyth G., Hu Y., Dunn P., Phipson B. 2010. statmod: Statistical Modeling. R package version 1.4.8. Available at: http://CRAN.R-project.org/package= statmod.
50. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004; 5:80; DOI: 10.1186/gb-2004-5-10-r80.
51. Simon R., Lam A., Li M.C., Ngan M., Menenzes S., Zhao Y. Analysis of gene expression data using BRB-array tools. Cancer Inform 2007; 3:11-17 (Pubitemid 47075796)
52. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125:279-284; DOI: 10.1016/S0166-4328(01)00297-2.
53. Saeed A.I., Bhagabati N.K., Braisted J.C., Liang W., Sharov V., Howe E.A., et al. TM4 microarray software suite. Methods Enzymol 2006; 411:134-193; DOI: 10.1016/S0076-6879(06)11009-5.